Patent Number definition

Patent Number means a reference number identifying a patent.
View Source
Patent Number. [*] PCT Patent Number: [*]
View Source
Patent Number. Application Serial Number: Issued or Published? Issue Date:
View Source

Examples of Patent Number in a sentence

  • The Shipowner is the sole owner of the whole of the Panamanian flag vessel, “[ ● ]” with Permanent Patent Number [ ● ], which is duly documented in the name of the Shipowner under the laws and flag of the Republic of Panama, which vessel is further described on Schedule I attached hereto and made a part hereof.

  • Gilead hereby grants Isis an exclusive, royalty-free, worldwide, assignable license (with the right to grant sublicenses) to U.S. Patent Number 5,256,775 beginning on the Effective Date and continuing until such time that Gilead settles the interference and the assignment to Isis becomes effective.

  • The Vessel is duly documented in the name of the Shipowner as owner under the laws of the Republic of Panama with the Permanent Patent Number set forth in Whereas Clause 1 hereof.

  • Docket Number Title Country Code Patent Number Application Number Application Date Grant Date Status The Units represented by this document are subject to restrictions on transfer and other terms and conditions set forth in this Agreement.

  • Country Case Type Status Title Filing Date Application Number Patent Number Grant Date Publication Number Publication Date [ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.

  • Company hereby grants VeriChip a fully-paid, royalty-free, perpetual, non-exclusive license to utilize Company’s U.S. Patent Number 5,952,935 for the purpose of designing and constructing, using, selling and offering to sell readers for human applications only.

  • LICENSEE shall not be required to indemnify LICENSOR for infringement of any U.S. or foreign patent or other intellectual property right covering or alleged to cover the exact EQWIP structure as described and claimed in LICENSOR's U.S. Patent Number 5,539,206; provided, that, LICENSEE does not join LICENSOR as a party defendant in any claim, cause of action, lawsuit or other proceeding filed or otherwise instituted against LICENSEE except as provided in 15.3.

  • Country Application No. Int’l Filing Date Patent Number Grant Date Ref .

  • Sublicensor is the licensee of Amoeba Corporation ("Licensor"), and has the right to grant a sublicense with respect to an invention entitled TV Terminator, described generally as an interactive universal remote control, including United States Patent Number 5,253,068 and Canadian patent number 2,107,736, and under any divisions, continuations, and continuations-in-part thereof, and under any patents that may issue thereon or any reissues or extensions thereof ("Amoeba Patent").

  • On June 1, 2000, Computer Motion amended its lawsuit to allege that we also infringe U.S. Patent Number 6,063,095.


More Definitions of Patent Number

Patent Number. 2019131 Date Granted and Issued: October 29, 1996 ▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇ISTRATION: Patent Number: 5,086,402 Date Granted and Issued: February 4, 1992 48 6 (ii) Other than the trade-mark ▇▇▇ositions and Section 45 actions to which Simware Inc. is a party (as disclosed in the following tables), there are no other proceedings or actions before any court, tribunal (including the United States Patent and Trademark Office ("PTO") or equivalent authority anywhere in the world) related to any Company Intellectual Property. PROCEEDINGS INITIATED BY THE CORPORATION I. OPPOSITIONS BY SIMWARE INC. CANADA (ACTIVE) TRADE-MARK & SERIAL NO. STATUS OF TAB APPLICANT & FILING DATE OPPOSITION --- ---------------- ------------- ---------- 65. OSIM & Design 855,156 Rule 42 evidence due Originalsim Inc. September 4, 1997 Applicants deadline: October 19, 1999 66. ORIGINALSIM 847,228 Rule 42 evidence due Originalsim Inc. June 6, 1997 Applicants deadline: October 19, 1999 67. SIMEX 848,389 Rule 41 evidence due ANDREAS RU(beta) June 18, 1997 Opponent's deadline: November 28, 1999
View Source
Patent Number. Sub Sta Abandon Date Grant Date BP6295 U.S.A. 02 Dec 1985 803222 4722928 ABN 02 Aug 1995 02 Feb 1988 BP6295 JAPAN 01 Dec 1986 86/284459 1966196 ISS 25 Aug 1995 BP6295 1 JAPAN 24 May 1993 93/121382 2017591 ISS 19 Feb 1996 BP6295A U.S.A. 01 Oct 1987 07/103213 ABN 01 Aug 1989 BP6295B U.S.A. 27 Jul 1989 07/391406 4990617 ISS 05 Feb 1991
View Source
Patent Number. 2154609 Title: HCMV Monocolonal Antibodies and their use in infection of HCMV injection and HCMV Specific IGM, methods of detect ING viral antigens Country: United Kingdom Next Renewal Due: 18 February 1998
View Source
Patent Number. Sub Sta Abandon Date Grant Date BP6322 U.S.A. 10 Sep 1986 905543 ABN 01 Jan 1989 BP6322A PHILIPPINES 10 Sep 1987 35798 ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ 08 Sep 1987 546354 ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ 10 Sep 1987 87/078224 607935 ISS 01 Aug 1991 BP6322A ISRAEL 09 Sep 1987 83842 83842 ISS 02 Oct 1991 BP6322A MALAYSIA 10 Sep 1987 ▇▇▇▇▇▇▇▇▇ MY101368A ISS 05 Sep 1991 BP6322A DENMARK 09 Sep 1987 87/004700 169071 ISS 08 Aug 1994 BP6322A IRELAND 09 Sep 1987 87/002406 60423 ISS 08 Jul 1994 BP6322A KOREA SOUTH 10 Sep 1987 87/010028 107765 ISS 15 Nov 1996 BP6322A HUNGARY 09 Sep 1987 87/004018 198016 ISS 19 Apr 1989 BP6322A PORTUGAL 09 Sep 1987 85668 85668 ▇▇▇ ▇▇ ▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇ 09 Sep 1987 87/224204 2110963 ISS 21 Nov 1996 BP6322A EUR PATENT 05 Sep 1987 87113010.0 0260555 ISS 22 Apr 1992 BP6322A BELGIUM 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A FRANCE 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A GREAT BRITAIN 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A ITALY 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A LUXEMBOURG 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A NETHERLANDS 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A SPAIN 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A SWEDEN 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A SWITZERLAND 05 Sep 1987 UNKN 0260555 ISS 22 Apr 1992 BP6322A GREECE 05 Sep 1987 UNKN 3004962 ISS 22 Apr 1992 BP6322A GERMANY 05 Sep 1987 P3778463.3-08 3778463 ISS 22 Apr 1992 BP6322A AUSTRIA 05 Sep 1987 UNKN E0075223 ISS 22 Apr 1992 Docket Number Country Name Appl. Date Applic. Number Patent Number Sub Sta Abandon Date Grant Date BP6322A RUSSIAN FED 09 Sep 1987 4203411/04 1582984 ISS 23 Dec 1988 BP6322A U.S.A. 16 Jul 1987 07/071028 4876269 ISS 24 Oct 1989 BP6322A FINLAND 09 Sep 1987 87/003896 88298 ISS 26 Apr 1993 BP6322A MEXICO 10 Sep 1987 008173 170515 ISS 27 Aug 1993 BP6322A NEW ZEALAND 08 Sep 1987 221726 221726 ISS 28 Aug 1990 BP6322A NORWAY 09 Sep 1987 87/003762 172934 ISS 29 Sep 1993 ▇▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇ 10 Sep 1987 87/006778 87/006778 ISS 30 May 1989 BP6322A TAIWAN 09 Sep 1987 76105341 031661 ISS 31 Jul 1989 DuPont Legal Patent Division License Agreement: NorthStar & Endo Pharmaceuticals DuP 769 Exhibit A 27 October 1997
View Source

Related to Patent Number

  • Relevant Number means the number specified as such in the applicable Final Terms (or, if no such number is specified, five);

  • Patent Application means an application for patent protection for an Invention with any domestic or foreign patent-issuing authority.

  • Project Number [project number] Library Cooperative Grant

  • Commercial user means a person who deals in children's products or who holds himself or herself out as having knowledge or skill relating to children's products, or a person who is in the business of remanufacturing, retrofitting, selling, leasing, subletting, or otherwise placing in the stream of commerce children's products.

  • Patent Applications means all published and unpublished nonprovisional and provisional patent applications, reexamination proceedings, invention disclosures and records of invention, applications for certificates of invention and priority rights, in any country and regardless of formal name, including without limitation, substitutions, continuations, continuations-in-part, divisions, renewals, revivals, reissues, re-examinations and extensions thereof.